Company news
Export licence approved
The company has been granted an Export Licence by the Federal Department of Health
Jan 2019
Good Manufacturing Practices licence granted
Company news
27 Oct 2020
Little Green Pharma was recently granted a Therapeutic Goods Administration (TGA) Good Manufacturing Practices (GMP) licence for its recently commissioned manufacturing facility in Western Australia. This license means:
- LGP will now be able to produce medicinal cannabis flower products
- LGP has the benefit of enhanced manufacturing capacity in addition to our existing pharmaceutical manufacturer
- strong supply reliability for patients
The GMP licencing of the Company’s manufacturing facility is the culmination of a two-year regulatory strategy.
Little Green Pharma now holds over 20 State and Federal operating authorisations, allowing it to operate a fully in-house and vertically-integrated cannabis cultivation, production, manufacturing, and wholesaling supply chain, capable of supplying various LGP branded medicinal cannabis products into Australian and international markets.
The manufacturing facility was constructed with funding support from the West Australian Government and represents a regional manufacturing success story for South West Western Australia.
You might also be interested in
Insights
Big plans for Little Green Pharma
Read more on the Australian firm hoping to help more UK patients benefit from medical cannabis.
Apr 2020
Insights
TGA announces final CBD down-scheduling
Registered CBD products to be dispensed over-the-counter without a prescription
Dec 2020